Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 15 (2024)
      • Volume 15 – Issue 1
      • Volume 15 – Issue 2
      • Volume 15 – Suppl. 1
    • VOLUME 14 (2023)
      • Volume 14 – Issue 3
      • Volume 14 – Issue 2
      • Volume 14 – Issue 1
      • Volume 14 – Suppl. 1
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: non-alcoholic fatty-liver disease

Non-alcoholic fatty liver disease and cardiovascular disease; from epidemiology to clinical and nutrition management: A narrative review

Maria Partsafa, Demosthenes Panagiotakos

 

Diagnostic methods and pharmacological management of non-alcoholic fatty liver disease – There is still room for improvement

Chrysoula Boutari, Panagiotis Pappas, Konstantinos Tziomalos, Vasileios Athyros, Asterios Karagiannis

Is non-alcoholic steatohepatitis in lean people a risk factor for liver or cardiovascular disease?

Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas, Georgios Sfikas, Charalambos Koumaras, Niki Katsiki, Vasilios Athyros

Evaluation of Different Scores to Predict Non-alcoholic Fatty Liver Disease in patients with type 2 diabetes

Angeliki M Angelidi, Athanasia Papazafiropoulou, Eleni-Margarita Tzouganatou, Konstantina Anagnostopoulou, Vasilis Velissaris, Vangelis Markakis, Ekaterini Vagena, Αndreas Melidonis

Hypolipidemic, Hepatoprotective and Anti-inflammatory Role of Chios Mastic gum in Streptozotocin-induced Diabetic Mice with Fatty Liver Disease

Aspasia Tzani, Evanthia Bletsa, Ilias P Doulamis, Laskarina-Maria Korou, Panagiotis Konstantopoulos, Ioannis S Vlachos, Ioannis Georgiadis, Despina N Perrea

CURRENT ISSUE

Abdominal Aortic KLF4 Expression in Hyperlipidemic Rabbits: Impact of Colchicine Regimens
Non-alcoholic fatty liver disease and cardiovascular disease; from epidemiology to clinical and nutrition management: A narrative review

Keywords

acute coronary syndrome (4) Arterial hypertension (4) arterial stiffness (5) Atherosclerosis (20) blood pressure (5) cardiovascular disease (28) cardiovascular diseases (6) Cardiovascular risk (6) childhood obesity (3) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (5) diabetes mellitus (9) diet (6) dyslipidemia (14) epidemiology (4) ezetimibe (5) Familial hypercholesterolemia (5) glucose (3) Heart failure (5) hypertension (9) inflammation (10) Ischemic stroke (3) lipoproteins (4) low-density lipoprotein cholesterol (3) Mediterranean diet (8) metabolic syndrome (7) morbidity (3) mortality (8) non-alcoholic fatty-liver disease (5) nonalcoholic fatty liver disease (3) obesity (9) omega-3 fatty acids (3) outcome (3) PCSK9 (3) PCSK9 inhibitors (5) physical activity (4) platelets (8) risk factors (3) smoking (3) statins (15) thrombosis (4) treatment (6) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2025
A SiteOrigin Theme